{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:30:56Z","timestamp":1788787856592,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Stiftung Neurochirurgische Forschung"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.cyto.2017.05.025","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T23:01:28Z","timestamp":1497135688000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Aneurysmal subarachnoid hemorrhage lead to systemic upregulation of IL-23\/IL-17 inflammatory axis"],"prefix":"10.1016","volume":"97","author":[{"given":"Shafqat Rasul","family":"Chaudhry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"G\u00fcresir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Vatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Kinfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alf","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cyto.2017.05.025_b0005","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/STROKEAHA.114.007006","article-title":"High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial","volume":"46","author":"Wong","year":"2015","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.cyto.2017.05.025_b0010","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ncpneuro0490","article-title":"Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution","volume":"3","author":"Macdonald","year":"2007","journal-title":"Nat. Clin. Pract. Neuro"},{"issue":"1","key":"10.1016\/j.cyto.2017.05.025_b0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","article-title":"Delayed neurological deterioration after subarachnoid haemorrhage","volume":"10","author":"Macdonald","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.cyto.2017.05.025_b0020","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.jcbfm.9600283","article-title":"Mechanisms of early brain injury after subarachnoid hemorrhage","volume":"26","author":"Cahill","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cyto.2017.05.025_b0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clineuro.2015.08.030","article-title":"Association of early inflammatory parameters after subarachnoid hemorrhage with functional outcome: a prospective cohort study","volume":"138","author":"Hollig","year":"2015","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.cyto.2017.05.025_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17040497","article-title":"Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review","volume":"17","author":"Lucke-Wold","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"Supplement","key":"10.1016\/j.cyto.2017.05.025_b0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-7091-1192-5_42","article-title":"Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: a review","volume":"115","author":"Provencio","year":"2013","journal-title":"Acta Neurochirurgica"},{"issue":"5","key":"10.1016\/j.cyto.2017.05.025_b0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.cyto.2017.05.025_b0045","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.05.025_b0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-065X.2008.00700.x","article-title":"Regulation of interleukin-12\/interleukin-23 production and the T-helper 17 response in humans","volume":"226","author":"Lyakh","year":"2008","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.cyto.2017.05.025_b0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2006.05.017","article-title":"Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology","volume":"25","author":"Uhlig","year":"2006","journal-title":"Immunity"},{"issue":"7318","key":"10.1016\/j.cyto.2017.05.025_b0060","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic TH17 cells in the absence of TGF-\u03b2 signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2017.05.025_b0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.psyneuen.2015.03.003","article-title":"Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia","volume":"56","author":"Borovcanin","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"5\u20136","key":"10.1016\/j.cyto.2017.05.025_b0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000360606","article-title":"Increased serum levels of interleukin-18, -23 and -17 in Chinese patients with Alzheimer's disease","volume":"38","author":"Chen","year":"2014","journal-title":"Dementia Geriatric Cogn. Disorders"},{"issue":"5","key":"10.1016\/j.cyto.2017.05.025_b0075","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/0300060513509130","article-title":"Associations between serum interleukin-23 levels and clinical characteristics in patients with systemic lupus erythematosus","volume":"42","author":"Du","year":"2014","journal-title":"J. Int. Med. Res."},{"issue":"6","key":"10.1016\/j.cyto.2017.05.025_b0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/1203475415584503","article-title":"IL-17A, IL-22, and IL-23 as Markers of Psoriasis Activity: A Cross-sectional Hospital-based Study","volume":"19","author":"Fotiadou","year":"2015","journal-title":"J. Cutaneous Med. Surg."},{"issue":"4","key":"10.1016\/j.cyto.2017.05.025_b0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/jdv.12124","article-title":"Serum concentration of IL-17, IL-23 and TNF-alpha among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test","volume":"28","author":"Atwa","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"1 Suppl","key":"10.1016\/j.cyto.2017.05.025_b0090","first-page":"S53","article-title":"Serum IL-23 in asthmatic children","volume":"26","author":"Ciprandi","year":"2012","journal-title":"J. Biol. regulat. Homeostatic Agents"},{"issue":"3","key":"10.1016\/j.cyto.2017.05.025_b0095","doi-asserted-by":"crossref","first-page":"e0119981","DOI":"10.1371\/journal.pone.0119981","article-title":"Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis","volume":"10","author":"Wendling","year":"2015","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2017.05.025_b0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2011.12.004","article-title":"Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients","volume":"244","author":"Wen","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2017.05.025_b0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2013.01.007","article-title":"The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23\/IL-17-mediated ischemic stroke in mice","volume":"257","author":"Ma","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.cyto.2017.05.025_b0110","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nm.1999","article-title":"Pivotal role of cerebral interleukin-17-producing \u03b3\u03b4 T cells in the delayed phase of ischemic brain injury","volume":"15","author":"Shichita","year":"2009","journal-title":"Nature Med."},{"issue":"3","key":"10.1016\/j.cyto.2017.05.025_b0115","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/STROKEAHA.114.006516","article-title":"Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the Interleukin 23\/Interleukin 17 Axis","volume":"46","author":"Abbas","year":"2015","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.cyto.2017.05.025_b0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2017.05.025_b0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2017.05.025_b0130","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2017.05.025_b0135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","article-title":"IL-17 family: cytokines, receptors and signaling","volume":"64","author":"Gu","year":"2013","journal-title":"Cytokine"},{"issue":"18","key":"10.1016\/j.cyto.2017.05.025_b0140","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/blood-2012-02-412726","article-title":"Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke","volume":"120","author":"Gelderblom","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cyto.2017.05.025_b0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/07853890.2011.577093","article-title":"Interleukin-23: a key cytokine in inflammatory diseases","volume":"43","author":"Duvallet","year":"2011","journal-title":"Ann. Med."},{"issue":"465","key":"10.1016\/j.cyto.2017.05.025_b0150","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aah6037","article-title":"Prostaglandin E2\u2013EP2\u2013NF-\u03baB signaling in macrophages as a potential therapeutic target for intracranial aneurysms","volume":"10","author":"Aoki","year":"2017","journal-title":"Sci. Signal."},{"issue":"12","key":"10.1016\/j.cyto.2017.05.025_b0155","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrneurol.2016.150","article-title":"Unruptured intracranial aneurysms: development, rupture and preventive management","volume":"12","author":"Etminan","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.cyto.2017.05.025_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12035-010-8155-z","article-title":"Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury","volume":"43","author":"Sehba","year":"2011","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.cyto.2017.05.025_b0170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMra052732","article-title":"Aneurysmal subarachnoid hemorrhage","volume":"354","author":"Suarez","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cyto.2017.05.025_b0175","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm1009-1131","article-title":"Bleeding in the brain: killer waves of depolarization in subarachnoid bleed","volume":"15","author":"Iadecola","year":"2009","journal-title":"Nat. Med."},{"issue":"3 suppl 1","key":"10.1016\/j.cyto.2017.05.025_b0180","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1161\/STROKEAHA.108.533315","article-title":"Subarachnoid hemorrhage: is it time for a new direction?","volume":"40","author":"Cahill","year":"2009","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.cyto.2017.05.025_b0185","first-page":"309","article-title":"From vasospasm to early brain injury: new frontiers in subarachnoid haemorrhage research","volume":"28","author":"Munoz-Guillen","year":"2013","journal-title":"Neurologia"},{"key":"10.1016\/j.cyto.2017.05.025_b0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1155\/2014\/384342","article-title":"Inflammation, Vasospasm, and brain injury after subarachnoid hemorrhage","volume":"2014","author":"Miller","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.cyto.2017.05.025_b0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s40064-015-0970-2","article-title":"Immune cells subpopulations in cerebrospinal fluid and peripheral blood of patients with Aneurysmal Subarachnoid Hemorrhage","volume":"4","author":"Moraes","year":"2015","journal-title":"SpringerPlus"},{"issue":"4","key":"10.1016\/j.cyto.2017.05.025_b0200","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.70.4.534","article-title":"Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries","volume":"70","author":"Fassbender","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cyto.2017.05.025_b0205","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1742-2094-9-255","article-title":"Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection","volume":"9","author":"Hopkins","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.cyto.2017.05.025_b0210","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1179\/016164101101199243","article-title":"Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage","volume":"23","author":"Takizawa","year":"2001","journal-title":"Neurol. Res."},{"issue":"1","key":"10.1016\/j.cyto.2017.05.025_b0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/STROKEAHA.110.594705","article-title":"Immunodepression after aneurysmal subarachnoid hemorrhage","volume":"42","author":"Sarrafzadeh","year":"2011","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.cyto.2017.05.025_b0220","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/ANA.0000000000000130","article-title":"Aneurysmal subarachnoid hemorrhage","volume":"27","author":"D'Souza","year":"2015","journal-title":"J. Neurosurg. Anesthesiol."},{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2017.05.025_b0225","first-page":"129","article-title":"Pleiotropic effects of cytokines: clinical and preclinical studies","volume":"12","author":"Bukowski","year":"1994","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"7","key":"10.1016\/j.cyto.2017.05.025_b0230","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/1352458510370791","article-title":"Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-\u03b21b","volume":"16","author":"Alexander","year":"2010","journal-title":"Multiple Sclerosis"},{"issue":"5","key":"10.1016\/j.cyto.2017.05.025_b0235","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI25308","article-title":"Anti\u2013IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis","volume":"116","author":"Chen","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cyto.2017.05.025_b0240","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbrc.2010.10.058","article-title":"Therapeutic effect of IL-12\/23 and their signaling pathway blockade on brain ischemia model","volume":"402","author":"Konoeda","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2017.05.025_b0245","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fncel.2014.00368","article-title":"\u03b3\u03b4 T cells as early sensors of tissue damage and mediators of secondary neurodegeneration","volume":"8","author":"Gelderblom","year":"2014","journal-title":"Front. Cell Neurosci."},{"issue":"10","key":"10.1016\/j.cyto.2017.05.025_b0250","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1161\/01.STR.30.10.2174","article-title":"Increased IL-1\u03b2, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study","volume":"30","author":"Kostulas","year":"1999","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.cyto.2017.05.025_b0255","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-3083.2005.01683.x","article-title":"Expression of Interleukin-17 in ischemic brain tissue","volume":"62","author":"Li","year":"2005","journal-title":"Scand. J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2017.05.025_b0260","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat. Med."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617301540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617301540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T03:19:02Z","timestamp":1750303142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617301540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":51,"alternative-id":["S1043466617301540"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.05.025","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aneurysmal subarachnoid hemorrhage lead to systemic upregulation of IL-23\/IL-17 inflammatory axis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}